Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,488,000 | 1,834,000 | 5,668,000 | 4,563,000 | 3,034,000 |
| Depreciation Amortization | 832,000 | 412,000 | 1,605,000 | 1,241,000 | 804,000 |
| Income taxes - deferred | N/A | N/A | -106,000 | N/A | N/A |
| Accounts receivable | -585,000 | -152,000 | -159,000 | -420,000 | -372,000 |
| Other Working Capital | -1,016,000 | -311,000 | 1,592,000 | 264,000 | 88,000 |
| Other Operating Activity | 774,000 | 152,000 | 264,000 | 420,000 | 372,000 |
| Operating Cash Flow | $3,493,000 | $1,935,000 | $8,864,000 | $6,068,000 | $3,926,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -674,000 | -332,000 | -1,568,000 | -824,000 | -518,000 |
| Net Acquisitions | -466,000 | -28,000 | -225,000 | -44,000 | -17,000 |
| Purchase Of Investment | -3,126,000 | -1,689,000 | -8,188,000 | -6,453,000 | -4,430,000 |
| Sale Of Investment | 3,942,000 | 2,023,000 | 5,967,000 | 5,288,000 | 3,649,000 |
| Other Investing Activity | -213,000 | -58,000 | -79,000 | -54,000 | -69,000 |
| Investing Cash Flow | $-537,000 | $-84,000 | $-4,093,000 | $-2,087,000 | $-1,385,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,189,000 | 272,000 | 338,000 | 235,000 | 187,000 |
| Debt Issued | 20,000 | 17,000 | 14,000 | 13,000 | 10,000 |
| Debt Repayment | -16,000 | -12,000 | -391,000 | -275,000 | -20,000 |
| Common Stock Issued | 227,000 | 164,000 | 514,000 | 399,000 | 294,000 |
| Common Stock Repurchased | -5,255,000 | -1,899,000 | -2,570,000 | -1,031,000 | -629,000 |
| Dividend Paid | -1,163,000 | -549,000 | -2,047,000 | -1,498,000 | -950,000 |
| Other Financing Activity | -219,000 | -156,000 | -1,109,000 | -1,033,000 | -938,000 |
| Financing Cash Flow | $-4,217,000 | $-2,163,000 | $-5,251,000 | $-3,190,000 | $-2,046,000 |
| Exchange Rate Effect | 109,000 | -9,000 | -40,000 | -3,000 | -51,000 |
| Beginning Cash Position | 3,758,000 | 3,758,000 | 4,278,000 | 4,278,000 | 4,278,000 |
| End Cash Position | 2,606,000 | 3,437,000 | 3,758,000 | 5,066,000 | 4,722,000 |
| Net Cash Flow | $-1,152,000 | $-321,000 | $-520,000 | $788,000 | $444,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,493,000 | 1,935,000 | 8,864,000 | 6,068,000 | 3,926,000 |
| Capital Expenditure | -802,000 | -350,000 | -1,731,000 | -978,000 | -571,000 |
| Free Cash Flow | 2,691,000 | 1,585,000 | 7,133,000 | 5,090,000 | 3,355,000 |